Super Micro Computer stock was rising ahead of Thursday’s opening bell, putting the artificial intelligence server maker on course for further gains. It’s finally giving investors reason to feel ...

In recent trading, shares of Supernus Pharmaceuticals Inc (Symbol: SUPN) have crossed above the average analyst 12-month target price of $39.25, changing hands for $39.41/share. When a stock ...

Supernus (SUPN) Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has approved an update for the label for Qelbree to include new pharmacodynamic data in Section 12.2. The ...

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share... MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX ...

Kids are participating in a viral trend known as the "Snow Angel Challenge." The activity involves people wearing bathing suits and making snow angels in their yards. Created by the Salvation Army ...

“The family continues to cope with the tragic loss of their beloved angel,” loved ones told 7NEWS. “Her memory will live on forever in the countless moments she gifted us. “Janaa’s smile ...

Angel Locsin informed her followers that she got her hacked X account back, marking her first social media activity amid her hiatus since 2022. Locsin shared the good news via her X page on ...

Angel Locsin has made her first social media post since 2022. Earlier this week, the actress’ X (formerly Twitter) account was hacked and shared posts about cryptocurrency and giveaways. Angel ...

In a report released yesterday, Andrew Tsai from Jefferies reiterated a Buy rating on Supernus Pharmaceuticals (SUPN – Research Report), with a price target of $40.00. The company’s shares ...

Better yet, you'd like to see the share price move up more than the market average. Unfortunately for shareholders, while the Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) share price is up 57% in the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...